PhoreMost
Latest round
- Series B
Last raised
- Aug 2024
Total raised
- $78M
Investors
- 10
About PhoreMost
Founded in 2014 and based in Cambridge, UK, PhoreMost Ltd is a biotechnology company that provides drug discovery and other pharmaceutical products and processes for cancer and other diseases. PhoreMost is a drug discovery company focused on identifying and developing therapies for difficult-to-target diseases. Utilizing its proprietary SITESEEKER® technology, the firm employs PROTEINi® libraries to discover novel drug targets and develop strategies for targeting them. The company is advancing a pipeline that includes programs in oncology and targeted protein degradation (TPD).
Who invested in PhoreMost
10 investors across 5 rounds
See all investors in PhoreMost
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PhoreMost
Who invested in PhoreMost?
PhoreMost has 10 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PhoreMost raised?
PhoreMost has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did PhoreMost last raise money?
PhoreMost's most recent round on record is a Series B, in Aug 2024.
What does PhoreMost do?
Founded in 2014 and based in Cambridge, UK, PhoreMost Ltd is a biotechnology company that provides drug discovery and other pharmaceutical products and processes for cancer and other diseases.
Where is PhoreMost headquartered?
PhoreMost is headquartered in Cambridge, UK.
Which VCs invest in companies like PhoreMost?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at PhoreMost's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like PhoreMost? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.